| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $33.3M | +291.4% | +2678.9% |
| Cost of Revenue | $24.3M | +305.4% | +3295.1% |
| Gross Profit | $9.0M | +258.1% | +1765.4% |
| R&D Expense | $3.4M | -17.5% | -41.1% |
| SG&A Expense | $19.8M | +3.6% | +14.7% |
| Operating Income | -$17.6M | +37.5% | +35.1% |
| Pre-tax Income | -$21.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $32.7M | +52.7% | -36.0% |
| Short-term Investments | $0 | -100.0% | — |
| Accounts Receivable | $2.2M | -50.5% | -3.2% |
| Inventory | $7.0M | — | +6468.2% |
| Current Assets | $103.2M | +8.8% | -21.6% |
| Total Assets | $281.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $921K | — | — |
| Capital Expenditures | $30.6M | — | — |
| Investing Cash Flow | -$32.8M | — | — |
| Financing Cash Flow | $63.4M | — | — |
| Free Cash Flow | -$29.7M | — | — |
| +35.2% |
| +20.0% |
| Income Tax | $5.5M | +167.0% | — |
| Net Income | -$26.8M | +23.2% | -0.8% |
| EPS (Basic) | -$0.16 | +27.3% | +11.1% |
| EPS (Diluted) | -$0.16 | +27.3% | +11.1% |
| +13.3% |
| +11.5% |
| Current Liabilities | $164.4M | +14.3% | +133.4% |
| Long-term Debt | $31.6M | +208.1% | — |
| Total Liabilities | $201.3M | +27.0% | +173.0% |
| Stockholders' Equity | $80.5M | -10.8% | -55.0% |